We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+10.49%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$11.9B
AUM Growth
+$2.55B
(+27%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
15.19%
Top 10 Holdings %
Top 10 Hldgs %
28.34%
Holding
1,181
New
44
Increased
774
Reduced
301
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$294M |
| 2 |
Apple
AAPL
|
+$74.6M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$68.1M |
| 4 |
Tesla
TSLA
|
+$64.9M |
| 5 |
Microsoft
MSFT
|
+$51.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$12.3M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$8.37M |
| 3 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$7.53M |
| 4 |
ASML
ASML
|
+$7.05M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$6.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.81% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 11.37% |
| 4 | Energy | 7.72% |
| 5 | Consumer Discretionary | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Revolution Medicines
RVMD
$38.8B
| $5.65M | 0.05% |
237,318
-30,535
| -11% | -$649K |
|
352
GE Aerospace
GE
$383B
| $5.63M | 0.05% |
107,848
+51,801
| +92% | +$2.55M |
|
353
CVR Energy
CVI
$3.31B
| $5.59M | 0.05% |
178,330
+23,025
| +15% | +$817K |
|
354
Humana
HUM
$45B
| $5.57M | 0.05% |
10,876
+4,107
| +61% | +$2.16M |
|
355
Equinix
EQIX
$102B
| $5.56M | 0.05% |
8,489
+3,034
| +56% | +$1.87M |
|
356
CareDx
CDNA
$2.48B
| $5.54M | 0.05% |
485,383
+193,438
| +66% | +$2.87M |
|
357
Zscaler
ZS
$25B
| $5.54M | 0.05% |
49,465
+1,581
| +3% | +$215K |
|
358
BridgeBio Pharma
BBIO
$15.7B
| $5.48M | 0.05% |
719,269
+128,529
| +22% | +$1.23M |
|
|
CMA
359
DELISTED
Comerica
CMA
| $5.48M | 0.05% |
81,903
+3,377
| +4% | +$234K |
|
360
Crown Castle
CCI
$33.5B
| $5.38M | 0.05% |
39,688
+13,745
| +53% | +$1.86M |
|
361
Kymera Therapeutics
KYMR
$8.25B
| $5.38M | 0.05% |
215,575
+35,933
| +20% | +$958K |
|
362
iShares MSCI Mexico ETF
EWW
$1.97B
| $5.31M | 0.04% |
107,328
+35,000
| +48% | +$1.76M |
|
363
CrowdStrike
CRWD
$206B
| $5.3M | 0.04% |
201,340
+176
| +0.1% | +$6.02K |
|
|
TELL
364
DELISTED
Tellurian Inc.
TELL
| $5.28M | 0.04% |
3,140,881
+1,366,214
| +77% | +$3.42M |
|
365
iShares TIPS Bond ETF
TIP
$14.5B
| $5.22M | 0.04% |
49,053
-11,280
| -19% | -$1.2M |
|
|
SBNY
366
DELISTED
Signature Bank
SBNY
| $5.19M | 0.04% |
45,073
+4,774
| +12% | +$656K |
|
367
Duke Energy
DUK
$96.9B
| $5.17M | 0.04% |
50,221
+21,621
| +76% | +$2.08M |
|
368
Air Products & Chemicals
APD
$65.2B
| $5.16M | 0.04% |
16,751
+5,644
| +51% | +$1.59M |
|
369
Brown & Brown
BRO
$24B
| $5.16M | 0.04% |
90,562
+10,043
| +12% | +$587K |
|
370
Cboe Global Markets
CBOE
$31.2B
| $5.12M | 0.04% |
40,836
+4,408
| +12% | +$544K |
|
371
Southern Company
SO
$107B
| $5.07M | 0.04% |
71,042
+31,513
| +80% | +$2.11M |
|
372
Novavax
NVAX
$1.22B
| $5.02M | 0.04% |
488,524
+270,106
| +124% | +$4.77M |
|
373
Everest Group
EG
$14.4B
| $5M | 0.04% |
15,104
+1,556
| +11% | +$485K |
|
374
Biohaven
BHVN
$2.01B
| $5M | 0.04% |
+360,232
| New | +$5.09M |
|
375
Keysight
KEYS
$55B
| $5M | 0.04% |
29,214
+2,318
| +9% | +$395K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Rafferty Asset Management held 1,181 positions worth $11.9B, up 27% from $9.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Rafferty Asset Management deployed $1.81B of net new capital in Q4 2022, opening 44 new positions and adding to 774 existing holdings. Its largest new stake was Akero Therapeutics: 187,799 shares worth $10.3M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Microchip Technology, an estimated $12.3M trimmed.
- Rafferty Asset Management's largest Q4 2022 buy was Akero Therapeutics: 187,799 shares worth $10.3M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q4 2022, an estimated $294M increase.
- Rafferty Asset Management's biggest Q4 2022 reduction was Microchip Technology, cutting an estimated $12.3M.
- Rafferty Asset Management fully exited CONTINENTAL RESOURCES INC. in Q4 2022, selling an estimated $7.53M.
- Rafferty Asset Management's ten largest holdings make up 28% of its $11.9B portfolio in Q4 2022.
- Rafferty Asset Management opened 44 new positions and closed 61 in Q4 2022.
- Rafferty Asset Management's portfolio value rose 27% quarter-over-quarter to $11.9B.
Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.